Literature DB >> 6780496

Precision radiotherapy for cancer of the pancreas: technique and results.

R R Dobelbower, B B Borgelt, K A Strubler, G J Kutcher, N Suntharalingam.   

Abstract

Entities:  

Mesh：

Year:  1980        PMID： 6780496     DOI： 10.1016/0360-3016(80)90164-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  7 in total

Review 1.  Current and emerging treatments for pancreatic cancer.

Authors:  W F Regine; W J John; M Mohiuddin
Journal:  Drugs Aging       Date:  1997-10       Impact factor: 3.923

2.  Treatment of cancer pain with noninvasive brain stimulation.

Authors:  Gisele Silva; Rebecca Miksad; Steven D Freedman; Alvaro Pascual-Leone; Sanjay Jain; Daniela L Gomes; Edson J Amancio; Paulo S Boggio; Claudio F Correa; Felipe Fregni
Journal:  J Pain Symptom Manage       Date:  2007-10       Impact factor: 3.612

3.  Intraoperative electron beam therapy for unresectable cancer of the pancreas.

Authors:  R R Dobelbower; A elTaki; F Bagne; M I Ajlouni; A J Milligan; D G Bronn
Journal:  Int J Pancreatol       Date:  1989-02

4.  Treatment of pancreatic cancer by radiation therapy.

Authors:  R R Dobelbower; A J Milligan
Journal:  World J Surg       Date:  1984-12       Impact factor: 3.352

5.  Study of treatment using percutaneous acetabuloplasty and interstitial implantation of (125)I seeds for patients with metastatic periacetabular tumors.

Authors:  Jinlei Zhang; Zuozhang Yang; Jiaping Wang; Jinde Wang; Pengjie Liu; Hongpu Sun; Kun Li; Yunshan Yang
Journal:  World J Surg Oncol       Date:  2012-11-20       Impact factor: 2.754

6.  Continuous and low-energy 125I seed irradiation changes DNA methyltransferases expression patterns and inhibits pancreatic cancer tumor growth.

Authors:  Jian-xia Ma; Zhen-dong Jin; Pei-ren Si; Yan Liu; Zheng Lu; Hong-yu Wu; Xue Pan; Luo-wei Wang; Yan-fang Gong; Jun Gao; Li Zhao-shen
Journal:  J Exp Clin Cancer Res       Date:  2011-04-02

7.  Adjuvant and neoadjuvant therapy for gastric cancer using epirubicin/cisplatin/5-fluorouracil (ECF) and alternative regimens before and after chemoradiation.

Authors:  T Leong; M Michael; K Foo; A Thompson; D Lim Joon; L Weih; S Ngan; R Thomas; J Zalcberg
Journal:  Br J Cancer       Date:  2003-10-20       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.